AZELASTINE FLUTICASO Spirig HC 0.14/0.05mg 120 dos
7680689800011
CH-68980
R01AD58
12.02.2.
1 / 3
google
Details
- Product number
- 6898001
- CPT
- -
- Packaging group
- 25
- Unit
- ml
- Composition
- azelastini hydrochloridum 0.137 mg, fluticasoni propionas 0.05 mg, glycerolum, cellulosum microcristallinum et carmellosum natricum, dinatrii edetas, polysorbatum 80, benzalkonii chloridum 0.014 mg, alcohol phenylethylicus, aqua purificata, ad suspensionem pro dosi, doses pro vase 120.
Articles (1)
Azelastin Fluticason Spirig HC Nasenspray, Suspension
suspension
25
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
0.137 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
0.05 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.014 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | Konservierungsstoff (Conservateur) |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 31.20
Specialties list
Yes
Generic
Yes
SL addition date:
01/03/2024
Authorization holder
Spirig HealthCare AG
4622 Egerkingen
Authorization information
- Swissmedic authorization number
- 68980
- Drug name
- Azelastin Fluticason Spirig HC Nasenspray, Suspension
- Galenic form
- NASSS
- ATC Code
- R01AD58
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 18/12/2023
- Authorization expiration date
- 17/12/2028
- IT number
- 12.02.2.
- Domain
- Human medicine
Packaging details
- Description (FR)
- AZELASTINE FLUTICASO Spirig HC 0.14/0.05mg 120 dos
- Description (DE)
- AZELASTIN FLUTICASON Spirig HC 0.14/0.05mg 120 Dos
- Market launch
- 18/12/2023
- Narcotic (BTM)
- No